Publications by authors named "Spencer D Revill"

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic interstitial lung disease of unknown etiology. The accumulation of macrophages is associated with disease pathogenesis. The unfolded protein response (UPR) has been linked to macrophage activation in pulmonary fibrosis.

View Article and Find Full Text PDF
Article Synopsis
  • - The study reveals that type I interferons (IFNs) are crucial for controlling viral infections and preventing excessive tissue damage, known as immunopathology, which can worsen disease outcomes.
  • - Researchers found that when the type I IFN receptor is absent, severe immunopathology occurs after viral infections due to macrophages and IL-6, and inhibiting these can reduce tissue damage.
  • - The research highlights that macrophage-derived matrix metalloproteinases (MMPs) are involved in tissue destruction during viral infections, suggesting that targeting MMPs could be a potential treatment strategy.
View Article and Find Full Text PDF
Article Synopsis
  • Cigarette smokers are more susceptible to severe influenza, facing higher risks of infection and hospitalization due to unclear immune mechanisms, prompting a study using a mouse model to explore these effects.
  • The study found that cigarette smoke exposure intensified symptoms of viral pneumonia, including increased viral RNA levels, and identified key cytokines like CSF3 and interleukin-6 that worsened the condition in smoke-exposed mice.
  • Results suggested potential therapeutic targets to mitigate the exacerbating effects of cigarette smoke on influenza, like managing excess viral RNA and targeting CSF3 receptor signaling.
View Article and Find Full Text PDF

Rationale: The accumulation of macrophages in the airways and the pulmonary interstitium is a hallmark of cigarette smoke-associated inflammation. Notably, pulmonary macrophages are not a homogenous population but consist of several subpopulations. To date, the manner in which cigarette smoke exposure affects the relative composition and functional capacity of macrophage subpopulations has not been elucidated.

View Article and Find Full Text PDF

Decellularization efforts must balance the preservation of the extracellular matrix (ECM) components while eliminating the nucleic acid and cellular components. Following effective removal of nucleic acid and cell components, decellularized ECM (dECM) can be solubilized in an acidic environment with the assistance of various enzymes to develop biological scaffolds in different forms, such as sheets, tubular constructs, or three-dimensional (3D) hydrogels. Each organ or tissue that undergoes decellularization requires a distinct and optimized protocol to ensure that nucleic acids are removed, and the ECM components are preserved.

View Article and Find Full Text PDF

Since the discovery of the myofibroblast over 50 years ago, much has been learned about its role in wound healing and fibrosis. Its origin, however, remains controversial, with a number of progenitor cells being proposed. Macrophage-myofibroblast transition (MMT) is a recent term coined in 2014 that describes the mechanism through which macrophages, derived from circulating monocytes originating in the bone marrow, transformed into myofibroblasts and contributed to kidney fibrosis.

View Article and Find Full Text PDF

The drug discovery pipeline, from discovery of therapeutic targets through preclinical and clinical development phases, to an approved product by health authorities, is a time-consuming and costly process, where a lead candidates' success at reaching the final stage is rare. Although the time from discovery to final approval has been reduced over the last decade, there is still potential to further optimize and streamline the evaluation process of each candidate as it moves through the different development phases. In this book chapter, we describe our preclinical strategies and overall decision-making process designed to evaluate the tolerability and efficacy of therapeutic candidates suitable for patients diagnosed with fibrotic lung disease.

View Article and Find Full Text PDF

Pulmonary fibrosis is a progressive lung disease characterized by myofibroblast accumulation and excessive extracellular matrix deposition. We sought to investigate the role of FKBP13 (13-kD FK506-binding protein), an endoplasmic reticulum-resident molecular chaperone, in various forms of pulmonary fibrosis. We first characterized the gene and protein expression of FKBP13 in lung biopsy specimens from 24 patients with idiopathic pulmonary fibrosis and 17 control subjects.

View Article and Find Full Text PDF
Article Synopsis
  • * Key predictors for this suboptimal response include reliance on daily prednisone, having sinus issues, and being diagnosed with late-onset asthma.
  • * Patients showing signs of worsening asthma often had signs of autoimmune activity, as indicated by specific biomarkers in their sputum, suggesting a more complex underlying condition may affect treatment efficacy.
View Article and Find Full Text PDF